Pierre Vandepapelière is a Chief Executive Officer, Chief Medical Officer and Founder at Amyl Therapeutics. Pierre Vandepapelière attended Université catholique de Louvain.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
![]() |
Chief Executive Officer, Chief Medical Officer and Founder | — | — | Detail |
![]() |
Board Member | — | — | Detail |